Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

CTHRC1 helps hair grow back, and plantar dermis mixture boosts it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Key genes and pathways, including Wnt, NF-Kappa, and JAK-STAT, are crucial for starting Pashmina fiber growth in goats.

Finasteride helps female-pattern hair loss.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Testosterone treatment may affect heart response to stress in transgender men.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

CRH can cause hair loss by promoting cell death in hair growth cells.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Cyproterone acetate effectively treats hirsutism and related conditions.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.